Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Nile Therapeutics, Inc. (the “ Company ”) hereby certifies, to such officer’s knowledge, that:

 

(1) the accompanying Quarterly Report on Form 10-Q of the Company for the quarterly period ended September 30, 2013 (the “ Report ”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

/s/ Daron Evans
Name: Daron Evans
Title: Chief Financial Officer